PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALK-positive lung cancer

Roche's Alecensa® (alectinib) Receives CFDA Priority Review for 1L ALK +ve mNSCLC

Roche's Alecensa® (alectinib) Receives CFDA Priority Review for 1L ALK +ve mNSCLC

August 21, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us